Vaccine for Enterotoxigenic E. coli – Travelers’ Diarrhoea

Vaccine for Enterotoxigenic E. coli – Travelers’ Diarrhoea

0:00

Louis Bourgeois, Johns Hopkins University, Baltimore Among the various experiences when visiting a developing country: there’s amazement at the sounds and the colour; delight at the warmth of th

Louis Bourgeois, Johns Hopkins University, BaltimoreAmong the various experiences when visiting a developing country: there’s amazement at the sounds and the colour; delight at the warmth of the people and the climate; but also, unfortunately, travelers’ diarrhea. But the main causal bacterium, enterotoxigenic E. coli – or ETEC – is also responsible for a large amount of morbidity and mortality among children who live in the developing world. So, interest was stoked at ICAAC by the possibility of an oral killed vaccine for travellers’ diarrhea which has now been used in a double blind, randomised study involving 1400 people.

Click here for all the interviews from ICAAC 2005

Related Episodes

Non-Perfect HIV Vaccine Could Still Have Major Benefits

Non-Perfect HIV Vaccine Could Still Have Major Benefits

ANTHONY FAUCI, National Institutes of Health, Bethesda REFERENCE: N Engl J Med 2007;356:2073-81 Is there any hope for an HIV vaccine? According to Anthony Fauci, of the National Institutes of Health i

Audio Journal of Oncology in Advance – January 1st, 2007 – Reporting from San Antonio Breast Cancer Symposium, December 14-17, 2006

Audio Journal of Oncology in Advance – January 1st, 2007 – Reporting from San Antonio Breast Cancer Symposium, December 14-17, 2006

Dennis Slamon George Peoples James Holland Massimo Christofanilli Trastuzumab: Mature Results in Early Breast Cancer Show Superiority REFERENCE: San Antonio Breast Cancer Symposium 2006, Abstract: 52